Antabuse: Clinically Proven Alcohol Dependence Treatment
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.44 | $39.56 (0%) | 🛒 Add to cart |
| 120 | $0.41 | $52.75 $49.02 (7%) | 🛒 Add to cart |
| 180 | $0.39 | $79.12 $70.52 (11%) | 🛒 Add to cart |
| 270 | $0.38 | $118.68 $101.48 (14%) | 🛒 Add to cart |
| 360 | $0.37
Best per pill | $158.24 $131.58 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.73 | $73.53 $65.36 (11%) | 🛒 Add to cart |
| 120 | $0.67 | $98.04 $80.84 (18%) | 🛒 Add to cart |
| 180 | $0.62 | $147.06 $111.80 (24%) | 🛒 Add to cart |
| 270 | $0.59 | $220.59 $159.10 (28%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $294.12 $208.12 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication used as an adjunct in the management of chronic alcohol dependence. It functions as an alcohol-sensitizing agent, creating a physiological response that discourages alcohol consumption. This medication is typically incorporated into a comprehensive treatment plan that includes counseling and support. Proper medical supervision is essential throughout treatment to ensure safety and efficacy.
Features
- Contains disulfiram as the active pharmaceutical ingredient
- Available in 250mg and 500mg oral tablets
- FDA-approved for alcohol dependence treatment
- Produces an aversive reaction when combined with alcohol
- Requires prescription and medical supervision
Benefits
- Creates a powerful psychological deterrent against alcohol consumption
- Supports long-term sobriety when combined with behavioral therapy
- Provides a tangible mechanism to reinforce treatment commitment
- Reduces alcohol craving through conditioned response
- Helps break the cycle of alcohol dependence
- Facilitates participation in comprehensive rehabilitation programs
Common use
Antabuse is primarily prescribed for patients committed to maintaining abstinence from alcohol as part of a supervised treatment program. It is indicated for individuals diagnosed with alcohol use disorder who have achieved initial abstinence and are motivated to remain alcohol-free. The medication is typically used during the maintenance phase of treatment rather than acute withdrawal management. Healthcare providers often recommend Antabuse for patients who have experienced previous relapses or require additional reinforcement to maintain sobriety. Treatment duration varies based on individual patient needs and response, often continuing for several months to years under medical supervision.
Dosage and direction
The initial dosage of Antabuse is typically 500mg daily for one to two weeks, administered as a single dose in the morning. Maintenance dosage is usually 250mg daily (range 125-500mg), adjusted based on patient tolerance and response. Tablets should be swallowed whole with water, preferably in the morning to maximize diurnal coverage. Treatment should only begin after the patient has abstained from alcohol for at least 12 hours and preferably longer. Dosage adjustments should be made under medical supervision, considering individual patient factors including liver function, age, and treatment response. The medication must be taken consistently to maintain the alcohol deterrent effect.
Precautions
Patients must be fully informed about the Antabuse-alcohol reaction and must avoid all alcohol-containing products, including medications, foods, and toiletries. Liver function tests should be monitored regularly during treatment due to potential hepatotoxicity. Caution is advised in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic renal failure, or cardiovascular disease. Patients should carry medical identification indicating they are taking disulfiram. Healthcare providers should assess patient motivation and comprehension of treatment requirements before initiation. Periodic psychiatric assessment is recommended as disulfiram may exacerbate pre-existing psychiatric conditions.
Contraindications
Antabuse is contraindicated in patients with severe myocardial disease or coronary artery disease due to potential cardiovascular effects during alcohol reactions. It should not be used in patients with psychosis or severe personality disorders. Contraindications include hypersensitivity to disulfiram or other thiuram derivatives used in pesticides and rubber vulcanization. The medication is not recommended for patients without their full knowledge and consent, or those who cannot reliably avoid alcohol-containing products. Use is contraindicated during pregnancy and breastfeeding unless clearly needed and under strict medical supervision.
Possible side effects
Common side effects include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, and skin eruptions. Less frequently, patients may experience peripheral neuropathy, optic neuritis, polyneuritis, and hepatic toxicity including hepatitis. Psychiatric effects such as depression, psychosis, and confusion have been reported. The most significant adverse effect is the disulfiram-alcohol reaction, characterized by flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, dyspnea, hyperventilation, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. Severe reactions may include respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death.
Drug interaction
Antabuse inhibits aldehyde dehydrogenase and several cytochrome P450 enzymes, potentially affecting metabolism of numerous medications. Significant interactions occur with alcohol-containing preparations, metronidazole, paraldehyde, phenytoin, warfarin, benzodiazepines, tricyclic antidepressants, and theophylline. Concurrent use with alcohol-containing medications, including some cough syrups and elixirs, can provoke disulfiram-alcohol reactions. Antabuse may potentiate the effects of warfarin and other oral anticoagulants, requiring dosage adjustment and frequent monitoring. Interaction with phenytoin may lead to phenytoin intoxication. Concurrent use with isoniazid may produce unsteadiness or marked personality changes.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. Patients should not double the dose to make up for a missed dose. Consistency in dosing is important to maintain the alcohol deterrent effect. If multiple doses are missed, patients should contact their healthcare provider before resuming treatment, as the protective effect against alcohol may be diminished. Medical guidance should be sought regarding appropriate restart procedures to ensure continued protection.
Overdose
Symptoms of Antabuse overdose may include nausea, vomiting, diarrhea, loss of appetite, abdominal pain, dizziness, headache, drowsiness, lethargy, incoordination, nervousness, irritability, and in severe cases, respiratory depression, cardiovascular collapse, seizures, and coma. Management includes gastric lavage if presented early, supportive care, and symptomatic treatment. There is no specific antidote for disulfiram overdose. Hemodialysis may be considered in severe cases. Patients should be monitored for hepatic and neurological toxicity for several days following overdose due to the drug’s long elimination half-life.
Storage
Antabuse tablets should be stored at controlled room temperature (20-25°C or 68-77°F) in their original container, protected from light and moisture. The medication should be kept out of reach of children and pets. Unused medication should be properly disposed of according to FDA guidelines or returned to a medication take-back program. Patients should check expiration dates and not use tablets that are discolored or show signs of deterioration.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Antabuse is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should not initiate or discontinue treatment without medical consultation. Individual response to medication may vary, and healthcare providers should consider each patient’s specific circumstances when prescribing. The complete prescribing information should be consulted before administration.
Reviews
Clinical studies demonstrate that Antabuse, when used as part of a comprehensive treatment program, significantly improves abstinence rates compared to placebo. Research indicates approximately 50-60% of compliant patients maintain sobriety during treatment periods. Patient reviews frequently note the medication’s effectiveness as a psychological deterrent, though some report challenges with side effects. Medical professionals emphasize that success correlates strongly with patient motivation, comprehensive support systems, and consistent medical supervision. Long-term outcomes are most favorable when Antabuse is combined with behavioral therapy and ongoing support.